The TMAO-Producing Enzyme Flavin-Containing Monooxygenase 3 Regulates Obesity and the Beiging of White Adipose Tissue

Cell Reports

Volumn 19, Issue 12, 2017, Pages 2451-2461

  Schugar, Rebecca C ^a   Shih, Diana M ^h   Warrier, Manya ^a   Helsley, Robert N ^a   Burrows, Amy ^a   Ferguson, Daniel ^a   Brown, Amanda L ^a   Gromovsky, Anthony D ^a   Heine, Markus ^g   Chatterjee, Arunachal ^a   Li, Lin ^a   Li, Xinmin S ^a   Wang, Zeneng ^a   Willard, Belinda ^a   Meng, YongHong ^h   Kim, Hanjun ^h   Che, Nam ^h   Pan, Calvin ^h   Lee, Richard G ^c   Crooke, Rosanne M ^c   Graham, Mark J ^c   Morton, Richard E ^a   Langefeld, Carl D ^b   Das, Swapan K ^b   Rudel, Lawrence L ^b   Zein, Nizar ^a   McCullough, Arthur J ^a   Dasarathy, Srinivasan ^a   Tang, W H Wilson ^a   Erokwu, Bernadette O ^f   Flask, Chris A ^f   Laakso, Markku ^d   Civelek, Mete ^e   Naga Prasad, Sathyamangla V ^a   Heeren, Joerg ^g   Lusis, Aldons J ^h   Hazen, Stanley L ^a   Brown, J Mark ^a   more..

^a LERNER RESEARCH INSTITUTE   (United States)

^b WAKE FOREST SCHOOL OF MEDICINE   (United States)

^c ISIS PHARMACEUTICALS   (United States)

^d UNIVERSITY OF EASTERN FINLAND   (Finland)

^e University of Virginia   (United States)

^f CASE WESTERN RESERVE UNIVERSITY   (United States)

^g UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

^h UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

adipose; diabetes; flavin containing monooxygenase 3; FMO3; microbiota; nutrition; obesity

Indexed keywords

ANTISENSE OLIGONUCLEOTIDE; DIMETHYLANILINE MONOOXYGENASE; FLAVIN CONTAINING MONOOXYGENASE 3; MESSENGER RNA; TRIMETHYLAMINE OXIDE; UNCLASSIFIED DRUG; DIMETHYLANILINE MONOOXYGENASE (N-OXIDE FORMING); METHYLAMINE; OXYGENASE; TRIMETHYLOXAMINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DIET INDUCED OBESITY; ENERGY EXPENDITURE; FEMALE; GENE DELETION; HUMAN; MAJOR CLINICAL STUDY; MALE; MOUSE; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; OBESITY; PRIORITY JOURNAL; WHITE ADIPOSE TISSUE; WHITE ADIPOSE TISSUE BEIGING; ANIMAL; BEIGE ADIPOCYTE; BLOOD; C57BL MOUSE; ENZYMOLOGY; GENE EXPRESSION; KNOCKOUT MOUSE; PATHOLOGY; PATHOPHYSIOLOGY; PHYSIOLOGY; SUBCUTANEOUS FAT;

ADIPOCYTES, BEIGE; ANIMALS; DIABETES MELLITUS, TYPE 2; FEMALE; GENE EXPRESSION; HUMANS; MALE; METHYLAMINES; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; OBESITY; OXYGENASES; SUBCUTANEOUS FAT;

EID: 85020846804     PISSN: None     EISSN: 22111247     Source Type: Journal    
DOI: 10.1016/j.celrep.2017.05.077     Document Type: Article

References (45)

1. Bäckhed, F., Ding, H., Wang, T., Hooper, L.V., Koh, G.Y., Nagy, A., Semenkovich, C.F., Gordon, J.I., The gut microbiota as an environmental factor that regulates fat storage. Proc. Natl. Acad. Sci. USA 101 (2004), 15718–15723.
2. Bartelt, A., Heeren, J., Adipose tissue browning and metabolic health. Nat. Rev. Endocrinol. 10 (2014), 24–36.
3. Bennett, B.J., de Aguiar Vallim, T.Q., Wang, Z., Shih, D.M., Meng, Y., Gregory, J., Allayee, H., Lee, R., Graham, M., Crooke, R., et al. Trimethylamine-N-oxide, a metabolite associated with atherosclerosis, exhibits complex genetic and dietary regulation. Cell Metab. 17 (2013), 49–60.
4. Brown, J.M., Betters, J.L., Lord, C., Ma, Y., Han, X., Yang, K., Alger, H.M., Melchior, J., Sawyer, J., Shah, R., et al. CGI-58 knockdown in mice causes hepatic steatosis but prevents diet-induced obesity and glucose intolerance. J Lipid Res. 51 (2010), 3306–3315.
5. Brown, J.M., Hazen, S.L., The gut microbial endocrine organ: bacterially derived signals driving cardiometabolic diseases. Annu. Rev. Med. 66 (2015), 343–359.
6. Cashman, J.R., Zhang, J., Human flavin-containing monooxygenases. Annu. Rev. Pharmacol. Toxicol. 46 (2006), 65–100.
7. Civelek, M., Wu, Y., Pan, C., Raulerson, C.K., Ko, A., He, A., Tilford, C., Saleem, N.K., Stančáková, A., Scott, L.J., et al. Genetic regulation of adipose gene expression and cardio-metabolic traits. Am. J. Hum. Genet. 100 (2017), 428–443.
8. Cox, L.M., Yamanishi, S., Sohn, J., Alekseyenko, A.V., Leung, J.M., Cho, I., Kim, S.G., Li, H., Gao, Z., Mahana, D., et al. Altering the intestinal microbiota during a critical developmental window has lasting metabolic consequences. Cell 158 (2014), 705–721.
9. Dambrova, M., Latkovskis, G., Kuka, J., Strele, I., Konrade, I., Grinberga, S., Hartmane, D., Pugovics, O., Erglis, A., Liepinsh, E., Diabetes is associated with higher trimethylamine N-oxide plasma levels. Exp. Clin. Endocrinol. Diabetes 124 (2016), 251–256.
10. Das, S.K., Sharma, N.K., Zhang, B., Integrative network analysis reveals different pathophysiological mechanisms of insulin resistance among Caucasians and African Americans. BMC Med. Genomics, 8, 2015, 4.
11. Gao, X., Liu, X., Xu, J., Xue, C., Xue, Y., Wang, Y., Dietary trimethylamine N-oxide exacerbates impaired glucose tolerance in mice fed a high fat diet. J. Biosci. Bioeng. 118 (2014), 476–481.
12. Gregory, J.C., Buffa, J.A., Org, E., Wang, Z., Levison, B.S., Zhu, W., Wagner, M.A., Bennett, B.J., Li, L., DiDonato, J.A., et al. Transmission of atherosclerosis susceptibility with gut microbial transplantation. J. Biol. Chem. 290 (2015), 5647–5660.
13. Jiang, X., Yan, J., West, A.A., Perry, C.A., Malysheva, O.V., Devapatla, S., Pressman, E., Vermeylen, F., Caudill, M.A., Maternal choline intake alters the epigenetic state of fetal cortisol-regulating genes in humans. FASEB J. 26 (2012), 3563–3574.
14. Koeth, R.A., Wang, Z., Levison, B.S., Buffa, J.A., Org, E., Sheehy, B.T., Britt, E.B., Fu, X., Wu, Y., Li, L., et al. Intestinal microbiota metabolism of L-carnitine, a nutrient in red meat, promotes atherosclerosis. Nat. Med. 19 (2013), 576–585.
15. Koeth, R.A., Levison, B.S., Culley, M.K., Buffa, J.A., Wang, Z., Gregory, J.C., Org, E., Wu, Y., Li, L., Smith, J.D., et al. γ-Butyrobetaine is a proatherogenic intermediate in gut microbial metabolism of L-carnitine to TMAO. Cell Metab. 20 (2014), 799–812.
16. Lever, M., George, P.M., Slow, S., Bellamy, D., Young, J.M., Ho, M., McEntyre, C.J., Elmslie, J.L., Atkinson, W., Molyneux, S.L., et al. Betaine and trimethylamine-N-oxide as predictors of cardiovascular outcomes show different patterns in diabetes mellitus: an observational study. PLoS ONE, 9, 2014, e114969.
17. Ley, R.E., Bäckhed, F., Turnbaugh, P., Lozupone, C.A., Knight, R.D., Gordon, J.I., Obesity alters gut microbial ecology. Proc. Natl. Acad. Sci. USA 102 (2005), 11070–11075.
18. Li, Q., Korzan, W.J., Ferrero, D.M., Chang, R.B., Roy, D.S., Buchi, M., Lemon, J.K., Kaur, A.W., Stowers, L., Fendt, M., Liberles, S.D., Synchronous evolution of an odor biosynthesis pathway and behavioral response. Curr. Biol. 23 (2013), 11–20.
19. Mafune, A., Iwamoto, T., Tsutsumi, Y., Nakashima, A., Yamamoto, I., Yokoyama, K., Yokoo, T., Urashima, M., Associations among serum trimethylamine-N-oxide (TMAO) levels, kidney function and infarcted coronary artery number in patients undergoing cardiovascular surgery: a cross-sectional study. Clin. Exp. Nephrol. 20 (2016), 731–739.
20. Matsuda, M., DeFronzo, R.A., Insulin sensitivity indices obtained from oral glucose tolerance testing: comparison with the euglycemic insulin clamp. Diabetes Care 22 (1999), 1462–1470.
21. Miao, J., Ling, A.V., Manthena, P.V., Gearing, M.E., Graham, M.J., Crooke, R.M., Croce, K.J., Esquejo, R.M., Clish, C.B., Vicent, D., Biddinger, S.B., Morbid Obesity Study Group. Flavin-containing monooxygenase 3 as a potential player in diabetes-associated atherosclerosis. Nat. Commun., 6, 2015, 6498.
22. Missailidis, C., Hällqvist, J., Qureshi, A.R., Barany, P., Heimbürger, O., Lindholm, B., Stenvinkel, P., Bergman, P., Serum trimethylamine-N-oxide is strongly related to renal function and predicts outcome in chronic kidney disease. PLoS ONE, 11, 2016, e0141738.
23. Muoio, D.M., Metabolic inflexibility: when mitochondrial indecision leads to metabolic gridlock. Cell 159 (2014), 1253–1262.
24. Parks, B.W., Nam, E., Org, E., Kostem, E., Norheim, F., Hui, S.T., Pan, C., Civelek, M., Rau, C.D., Bennett, B.J., et al. Genetic control of obesity and gut microbiota composition in response to high-fat, high-sucrose diet in mice. Cell Metab. 17 (2013), 141–152.
25. Poly, C., Massaro, J.M., Seshadri, S., Wolf, P.A., Cho, E., Krall, E., Jacques, P.F., Au, R., The relation of dietary choline to cognitive performance and white-matter hyperintensity in the Framingham Offspring Cohort. Am. J. Clin. Nutr. 94 (2011), 1584–1591.
26. Puigserver, P., Wu, Z., Park, C.W., Graves, R., Wright, M., Spiegelman, B.M., A cold-inducible coactivator of nuclear receptors linked to adaptive thermogenesis. Cell 92 (1998), 829–839.
27. Romano, K.A., Vivas, E.I., Amador-Noguez, D., Rey, F.E., Intestinal microbiota composition modulates choline bioavailability from diet and accumulation of the proatherogenic metabolite trimethylamine-N-oxide. MBio, 6, 2015, e02481.
28. Sharma, N.K., Sajuthi, S.P., Chou, J.W., Calles-Escandon, J., Demons, J., Rogers, S., Ma, L., Palmer, N.D., McWilliams, D.R., Beal, J., et al. Tissue-specific and genetic regulation of insulin sensitivity-associated transcripts in African Americans. J. Clin. Endocrinol. Metab. 101 (2016), 1455–1468.
29. Shaw, G.M., Finnell, R.H., Blom, H.J., Carmichael, S.L., Vollset, S.E., Yang, W., Ueland, P.M., Choline and risk of neural tube defects in a folate-fortified population. Epidemiology 20 (2009), 714–719.
30. Shih, D.M., Wang, Z., Lee, R., Meng, Y., Che, N., Charugundla, S., Qi, H., Wu, J., Pan, C., Brown, J.M., et al. Flavin containing monooxygenase 3 exerts broad effects on glucose and lipid metabolism and atherosclerosis. J. Lipid Res. 56 (2015), 22–37.
31. Stancáková, A., Kuulasmaa, T., Paananen, J., Jackson, A.U., Bonnycastle, L.L., Collins, F.S., Boehnke, M., Kuusisto, J., Laakso, M., Association of 18 confirmed susceptibility loci for type 2 diabetes with indices of insulin release, proinsulin conversion, and insulin sensitivity in 5,327 nondiabetic Finnish men. Diabetes 58 (2009), 2129–2136.
32. Suzuki, T., Heaney, L.M., Bhandari, S.S., Jones, D.J., Ng, L.L., Trimethylamine N-oxide and prognosis in acute heart failure. Heart 102 (2016), 841–848.
33. Tang, W.H., Wang, Z., Levison, B.S., Koeth, R.A., Britt, E.B., Fu, X., Wu, Y., Hazen, S.L., Intestinal microbial metabolism of phosphatidylcholine and cardiovascular risk. N. Engl. J. Med. 368 (2013), 1575–1584.
34. Tang, W.H., Wang, Z., Fan, Y., Levison, B., Hazen, J.E., Donahue, L.M., Wu, Y., Hazen, S.L., Prognostic value of elevated levels of intestinal microbe-generated metabolite trimethylamine-N-oxide in patients with heart failure: refining the gut hypothesis. J. Am. Coll. Cardiol. 64 (2014), 1908–1914.
35. Tang, W.H., Wang, Z., Li, X.S., Fan, Y., Li, D.S., Wu, Y., Hazen, S.L., Increased trimethylamine N-oxide portends high mortality risk independent of glycemic control in patients with type 2 diabetes mellitus. Clin. Chem. 63 (2017), 297–306.
36. Thomas, G., Betters, J.L., Lord, C.C., Brown, A.L., Marshall, S., Ferguson, D., Sawyer, J., Davis, M.A., Melchior, J.T., Blume, L.C., et al. The serine hydrolase ABHD6 is a critical regulator of the metabolic syndrome. Cell Rep. 5 (2013), 508–520.
37. Trøseid, M., Ueland, T., Hov, J.R., Svardal, A., Gregersen, I., Dahl, C.P., Aakhus, S., Gude, E., Bjørndal, B., Halvorsen, B., et al. Microbiota-dependent metabolite trimethylamine-N-oxide is associated with disease severity and survival of patients with chronic heart failure. J. Intern. Med. 277 (2015), 717–726.
38. Turnbaugh, P.J., Gordon, J.I., The core gut microbiome, energy balance and obesity. J. Physiol. 587 (2009), 4153–4158.
39. Ussar, S., Lee, K.Y., Dankel, S.N., Boucher, J., Haering, M.F., Kleinridders, A., Thomou, T., Xue, R., Macotela, Y., Cypess, A.M., et al. ASC-1, PAT2, and P2RX5 are cell surface markers for white, beige, and brown adipocytes. Sci. Transl. Med., 6, 2014, 247ra103.
40. Wang, Z., Klipfell, E., Bennett, B.J., Koeth, R., Levison, B.S., Dugar, B., Feldstein, A.E., Britt, E.B., Fu, X., Chung, Y.M., et al. Gut flora metabolism of phosphatidylcholine promotes cardiovascular disease. Nature 472 (2011), 57–63.
41. Wang, Z., Tang, W.H., Buffa, J.A., Fu, X., Britt, E.B., Koeth, R.A., Levison, B.S., Fan, Y., Wu, Y., Hazen, S.L., Prognostic value of choline and betaine depends on intestinal microbiota-generated metabolite trimethylamine-N-oxide. Eur. Heart J. 35 (2014), 904–910.
42. Wang, Z., Roberts, A.B., Buffa, J.A., Levison, B.S., Zhu, W., Org, E., Gu, X., Huang, Y., Zamanian-Daryoush, M., Culley, M.K., et al. Non-lethal inhibition of gut microbial trimethylamine production for the treatment of atherosclerosis. Cell 163 (2015), 1585–1595.
43. Warrier, M., Shih, D.M., Burrows, A.C., Ferguson, D., Gromovsky, A.D., Brown, A.L., Marshall, S., McDaniel, A., Schugar, R.C., Wang, Z., et al. The TMAO-generating enzyme flavin monooxygenase 3 is a central regulator of cholesterol balance. Cell Rep. 10 (2015), 1–13.
44. Wu, J., Boström, P., Sparks, L.M., Ye, L., Choi, J.H., Giang, A.H., Khandekar, M., Virtanen, K.A., Nuutila, P., Schaart, G., et al. Beige adipocytes are a distinct type of thermogenic fat cell in mouse and human. Cell 150 (2012), 366–376.
45. Zhu, W., Gregory, J.C., Org, E., Buffa, J.A., Gupta, N., Wang, Z., Li, L., Fu, X., Wu, Y., Mehrabian, M., et al. Gut microbial metabolite TMAO enhances platelet hyperreactivity and thrombosis risk. Cell 165 (2016), 111–124.